Literature DB >> 19901077

Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.

Kian-Huat Lim1, Donita C Brady, David F Kashatus, Brooke B Ancrile, Channing J Der, Adrienne D Cox, Christopher M Counter.   

Abstract

The small GTPase Ras, which transmits extracellular signals to the cell, and the kinase Aurora-A, which promotes proper mitosis, can both be inappropriately activated in human tumors. Here, we show that Aurora-A in conjunction with oncogenic Ras enhances transformed cell growth. Furthermore, such transformation and in some cases also tumorigenesis depend upon S194 of RalA, a known Aurora-A phosphorylation site. Aurora-A promotes not only RalA activation but also translocation from the plasma membrane and activation of the effector protein RalBP1. Taken together, these data suggest that Aurora-A may converge upon oncogenic Ras signaling through RalA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901077      PMCID: PMC2798468          DOI: 10.1128/MCB.00916-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

Review 1.  Aurora-A - a guardian of poles.

Authors:  Tomotoshi Marumoto; Dongwei Zhang; Hideyuki Saya
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

2.  RalA-exocyst-dependent recycling endosome trafficking is required for the completion of cytokinesis.

Authors:  Xiao-Wei Chen; Mayumi Inoue; Shu C Hsu; Alan R Saltiel
Journal:  J Biol Chem       Date:  2006-10-06       Impact factor: 5.157

Review 3.  Cell cycle kinases in cancer.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Curr Opin Genet Dev       Date:  2007-02       Impact factor: 5.578

4.  Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.

Authors:  Kian-Huat Lim; Kevin O'Hayer; Stacey J Adam; S Disean Kendall; Paul M Campbell; Channing J Der; Christopher M Counter
Journal:  Curr Biol       Date:  2006-12-19       Impact factor: 10.834

5.  Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry.

Authors:  Espen Burum-Auensen; Paula M De Angelis; Aasa R Schjølberg; Katherine L Kravik; Marit Aure; Ole Petter F Clausen
Journal:  J Histochem Cytochem       Date:  2007-01-22       Impact factor: 2.479

6.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

7.  Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.

Authors:  X Wang; Y-X Zhou; W Qiao; Y Tominaga; M Ouchi; T Ouchi; C-X Deng
Journal:  Oncogene       Date:  2006-05-22       Impact factor: 9.867

Review 8.  Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?

Authors:  Gretchen A Repasky; Emily J Chenette; Channing J Der
Journal:  Trends Cell Biol       Date:  2004-11       Impact factor: 20.808

9.  Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models.

Authors:  Dongwei Zhang; Toru Hirota; Tomotoshi Marumoto; Michio Shimizu; Naoko Kunitoku; Takashi Sasayama; Yoshimi Arima; Liping Feng; Misao Suzuki; Motohiro Takeya; Hideyuki Saya
Journal:  Oncogene       Date:  2004-11-18       Impact factor: 9.867

10.  Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus.

Authors:  A Quaroni; E C Paul
Journal:  J Cell Sci       Date:  1999-03       Impact factor: 5.285

View more
  73 in total

1.  RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.

Authors:  Vincent Neyraud; Vasily N Aushev; Anastassia Hatzoglou; Brigitte Meunier; Ilaria Cascone; Jacques Camonis
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

2.  Driver mutations: a roadmap for getting close and personal in pancreatic cancer.

Authors:  Murray Korc
Journal:  Cancer Biol Ther       Date:  2010-09-24       Impact factor: 4.742

Review 3.  Aurora kinase inhibitors as anticancer molecules.

Authors:  Hiroshi Katayama; Subrata Sen
Journal:  Biochim Biophys Acta       Date:  2010-09-20

Review 4.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

Review 5.  Inhibition of Ras for cancer treatment: the search continues.

Authors:  Antonio T Baines; Dapeng Xu; Channing J Der
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

6.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

7.  Aurora kinase A localises to mitochondria to control organelle dynamics and energy production.

Authors:  Giulia Bertolin; Anne-Laure Bulteau; Marie-Clotilde Alves-Guerra; Agnes Burel; Marie-Thérèse Lavault; Olivia Gavard; Stephanie Le Bras; Jean-Philippe Gagné; Guy G Poirier; Roland Le Borgne; Claude Prigent; Marc Tramier
Journal:  Elife       Date:  2018-08-02       Impact factor: 8.140

8.  RalA is overactivated in medulloblastoma.

Authors:  Kevin F Ginn; Ben Fangman; Kaoru Terai; Amanda Wise; Daniel Ziazadeh; Kushal Shah; Robyn Gartrell; Brandon Ricke; Kyle Kimura; Sharad Mathur; Emma Borrego-Diaz; Faris Farassati
Journal:  J Neurooncol       Date:  2016-08-26       Impact factor: 4.130

Review 9.  Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Authors:  Katalin Hegyi; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2012-07-29       Impact factor: 3.201

10.  Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.

Authors:  Warapen Treekitkarnmongkol; Hiroshi Katayama; Kazuharu Kai; Kaori Sasai; Jennifer Carter Jones; Jing Wang; Li Shen; Aysegul A Sahin; Mihai Gagea; Naoto T Ueno; Chad J Creighton; Subrata Sen
Journal:  Carcinogenesis       Date:  2016-09-13       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.